These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 22204993

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
    Minakata D, Fujiwara SI, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Mashima K, Umino K, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Sugimoto M, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Ohmori T, Kanda Y.
    Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
    Satokawa H, Iwaya F, Igari T, Abe T, Hagiwara K, Tanji M, Watanabe M, Midorikawa H, Sato Y, Takase S.
    Kyobu Geka; 1990 Apr; 43(4):271-5. PubMed ID: 2112659
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Gabexate as a therapy for disseminated intravascular coagulation.
    Umeki S, Adachi M, Watanabe M, Yaji S, Soejima R.
    Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
    [Abstract] [Full Text] [Related]

  • 29. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
    Yamazaki M, Asakura H, Aoshima K, Saito M, Jokaji H, Uotani C, Kumabashiri I, Morishita E, Ikeda T, Matsuda T.
    Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
    [Abstract] [Full Text] [Related]

  • 30. First day dynamic changes in antithrombin III activity after supplementation have a predictive value in critically ill patients.
    Gando S, Sawamura A, Hayakawa M, Hoshino H, Kubota N, Oshiro A.
    Am J Hematol; 2006 Dec; 81(12):907-14. PubMed ID: 16924643
    [Abstract] [Full Text] [Related]

  • 31. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H, Scrobohaci ML, Ghorra P, Zini JM, Daniel MT, Castaigne S, Degos L.
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [Abstract] [Full Text] [Related]

  • 32. [Evaluation of FOY therapy for DIC or pre-DIC associated with neurosurgical disease].
    Wakui K, Takemae T, Kobayashi S.
    No Shinkei Geka; 1990 Jul; 18(7):609-17. PubMed ID: 2118601
    [Abstract] [Full Text] [Related]

  • 33. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
    Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S.
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
    [Abstract] [Full Text] [Related]

  • 34. 6,7-Dihydroxy-3-phenylcoumarin inhibits thromboplastin induced disseminated intravascular coagulation.
    Tunali T, Yarat A, Bulut M, Emekli N.
    Br J Haematol; 2004 Jul; 126(2):226-30. PubMed ID: 15238144
    [Abstract] [Full Text] [Related]

  • 35. Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery.
    Nishiyama T, Yokoyama T, Yamashita K.
    J Anesth; 2006 Jul; 20(3):179-82. PubMed ID: 16897236
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
    Hofmann M, Rest A, Hafner G, Tanner B, Brockerhoff P, Weilemann LS.
    Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. High mobility group B1 levels in sepsis and Disseminated Intravascular Coagulation.
    Eskici ZM, Açıkgöz Ş, Pişkin N, Mungan G, Can M, Güven B, Köktürk F.
    Acta Biochim Pol; 2012 Aug; 59(4):561-6. PubMed ID: 23094260
    [Abstract] [Full Text] [Related]

  • 40. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
    Wada H, Sakuragawa N, Shiku H.
    Semin Thromb Hemost; 1998 Aug; 24(3):293-7. PubMed ID: 9701463
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.